Pulmonary fibrosis is a lung disease where the air sacs and tissue in the lungs get stiff and scarred. This makes it harder to breathe and perform everyday activities. The ...

After a diagnosis of idiopathic pulmonary fibrosis at 78, Houghton Hutcheson continues to live his life and chooses not to ...

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible lung disease associated with poor quality of ...

Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver ...

Opportunities in the IPF market include developing targeted therapies due to rising prevalence in the 7MM, focusing on male and elderly populations, understanding regional trends for strategic ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

Diabetes mellitus (DM) is a possible risk factor for post-COVID-19 pulmonary fibrosis (PCPF), according to meta-analysis study findings published in BMC Pulmonary Medicine.

A wearable device combined with machine learning may offer a solution for continuous cough monitoring in pulmonary fibrosis patients. A wearable cough monitor generated clinically useful cough data, ...

“When we blocked chitinase-like proteins in mice, we were able to reverse some of the damage,” said Dr. Tara Sutherland, lead ...

Exposures before birth and in early life, including paternal smoking and maternal obesity, are key predictors of lung health and aging.

At 6 months old, Tony Arenas of Sussex was diagnosed with cystic fibrosis. On Sept. 5, Arenas was diagnosed with stage 4 ...